Page 1 - GUIAS ESC ESH 2018

ESC/ESH GUIDELINES
European Heart Journal (2018) 00,1–98
doi:10.1093/eurheartj/ehy339

2018 ESC/ESH Guidelines for the management

of arterial hypertension

The Task Force for the management of arterial hypertension of the
European Society of Cardiology (ESC) and the European Society of
Hypertension (ESH)

Authors/Task Force Members: Bryan Williams* (ESC Chairperson) (UK),
Giuseppe Mancia* (ESH Chairperson) (Italy), Wilko Spiering (The Netherlands),
Enrico Agabiti Rosei (Italy), Michel Azizi (France), Michel Burnier (Switzerland),
Denis L. Clement (Belgium), Antonio Coca (Spain), Giovanni de Simone (Italy),
Anna Dominiczak (UK), Thomas Kahan (Sweden), Felix Mahfoud (Germany),
†
Josep Redon (Spain), Luis Ruilope (Spain), Alberto Zanchetti (Italy), Mary Kerins
(Ireland), Sverre E. Kjeldsen (Norway), Reinhold Kreutz (Germany),
Stephane Laurent (France), Gregory Y. H. Lip (UK), Richard McManus (UK),
Krzysztof Narkiewicz (Poland), Frank Ruschitzka (Switzerland),
Roland E. Schmieder (Germany), Evgeny Shlyakhto (Russia), Costas Tsioufis
(Greece), Victor Aboyans (France), Ileana Desormais (France)

* Corresponding authors. Bryan Williams, Institute of Cardiovascular Science, University College London, Maple House, 1st Floor, Suite A, 149 Tottenham Court Road, London
W1T 7DN, UK, Tel: þ44 (0) 20 3108 7907, E-mail: bryan.williams@ucl.ac.uk. Giuseppe Mancia, University of Milano-Bicocca, Milan, Italy; and Hypertension Center Istituto
Universitario Policlinico di Monza, Verano (MB), Piazza dei Daini, 4 – 20126 Milan, Italy, Tel: þ39 347 4327142, E-mail: giuseppe.mancia@unimib.it
†
Professor Zanchetti died towards the end of the development of these Guidelines, in March 2018. He contributed fully to the development of these Guidelines, as a member
of the Guidelines’ Task Force and as a section co-ordinator. He will be sadly missed by colleagues and friends.
The two chairpersons contributed equally to the document.
ESC Committee for Practice Guidelines (CPG), European Society of Hypertension (ESH) Council, ESC National Cardiac Societies having participated in
the review process, ESH National Hypertension Societies having participated in the review process: listed in the Appendix.
ESC entities having participated in the development of this document:
Associations: European Association of Cardiovascular Imaging (EACVI), European Association of Preventive Cardiology (EAPC), European Association of Percutaneous
Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA).
Councils: Council for Cardiology Practice, Council on Cardiovascular Nursing and Allied Professions, Council on Cardiovascular Primary Care, Council on Hypertension,
Council on Stroke.
Working Groups: Cardiovascular Pharmacotherapy, Coronary Pathophysiology and Microcirculation, e-Cardiology.
Disclaimer. The ESC/ESH Guidelines represent the views of the ESC and ESH and were produced after careful consideration of the scientific and medical knowledge and the evidence
available at the time of their dating. The ESC and ESH are not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/ESH Guidelines and any other
official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are
encouraged to take the ESC/ESH Guidelines fully into account when exercising their clinical judgment as well as in the determination and the implementation of preventive, diagnostic, or
therapeutic medical strategies. However, the ESC/ESH Guidelines do not override in any way whatsoever the individual responsibility of health professionals to make appropriate and accu-
rate decisions in consideration of each patient’s health condition, and in consultation with that patient and the patient’s caregiver where appropriate and/or necessary. Nor do the ESC/ESH
Guidelines exempt health professionals from taking careful and full consideration of the relevant official updated recommendations or guidelines issued by the competent public health
authorities in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s
responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
The content of these European Society of Cardiology (ESC) and European Society of Hypertension (ESH) Guidelines has been published for personal and educational use only.
No commercial use is authorized. No part of the ESC/ESH Guidelines may be translated or reproduced in any form without written permission from the ESC or ESH.
Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle
such permissions on behalf of the ESC (journals.permissions@oup.com).
This article has been co-published in the European Heart Journal (doi: 10.1093/eurheartj/ehy339) and Journal of Hypertension (doi:10.1097/HJH. 10.1097/HJH.0000000000001940), and in
a shortened version in Blood Pressure. All rights reserved. VEuropean Society of Cardiology and European Society of Hypertension 2018. The articles in European Heart Journal and
C
Journal of Hypertension are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Any citation can be used when citing this article.

Downloaded from https://academic.oup.com/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehy339/5079119
by guest
on 27 August 2018